"We are excited to announce Pfizer’s proposed acquisition of Biohaven, recognizing the market leadership of Nurtec, our breakthrough all in one migraine therapy," said CEO Vlad Coric.

Jim Cramer says there are many investors who believe Rivian will become the next Tesla and they're willing to buy in at any price.

Jim Cramer says that sometimes, good news for a stock also can be good news for investors.

Cramer says the clouds over Wall Street may have broken. Get ready for next week's earnings parade.

Jim Cramer says investors can make money in cybersecurity, self-care products, the digitization of everything and financial empowerment.

Jim Cramer dismisses the parade of bearish pundits and says the markets tell us inflation is transitory and prices are returning to normal levels.

TheStreet's Jim Cramer takes a hard look at Boeing and AbbVie.

The Food and Drug Administration’s cleared SeaSpine's 7D Percutaneous Spine Module for spinal surgery. The company's shares are higher.

Biohaven's Nurtec was approved for migraine treatment in February 2020 and for prevention this past May. Q2 sales: $93 million.

The billionaire and crypto investor was in business with Voyager Digital which went bankrupt early July.

The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.

China is a crucial country for Tesla for its domination of the market of electric vehicles.